Please be aware that we only offer visits to a few selected locations. Please specify your preferred location and we will revert to you as soon as we can.

Sorry, something went wrong!

Thank you!

<div class="content news-content archive" role="main"> 
 <div class="news-page article"> 
  <h1>New directors elected in Statoil&nbsp;</h1> 
  <div class="date"> 
   <div class="date-module"> 
    <div class="date-module"> <span class="date_module-icon fa fa-calendar"></span> <span>June 23, 2005, 10:40 CEST</span> 
    </div> 
   </div> 
  </div> 
  <div class="text parbase section">
   <div class="component-container base undefined " data-emptytext="Text"> 
    <div class="articleBody"> 
     <p>Ingrid Wiik and Lars Thunell were elected as new members of Statoil's (OSE: STL; NYSE: STO) board of directors by the corporate assembly on 22 June.</p> 
     <p>Ingrid Wiik (60) is president and CEO of Alpharma in New York. She has held various managerial posts in Apothekernes Laboratorium/Alpharma, and has been CEO in the USA since 2000. Ms Wiik is a director of Coloplast in Denmark and Norske Skog in Norway.</p> 
     <p>Lars Thunell (56) is chief executive of SE-Banken, Stockholm. He was deputy managing director of ABB before becoming deputy chief executive of Nordbanken, chief executive of Securum and chief executive of Trygg-Hansa until its merger with SE-Banken. Mr Thunell is a director of Akzo Nobel (Sweden), the Swedish Bankers' Association and B-business partners (Sweden).</p> 
     <p>Eli Sætersmoen withdraws from the board with effect from 22 June.</p> 
    </div> 
   </div>
  </div> 
 </div>  
</div>